View Document Preview and Link
Document Date: 2015-01-16 09:25:49 Open Document File Size: 287,35 KB Share Result on Facebook
City Placebo Reference / Reference / / Company Age Group / Valeant Pharmaceuticals North America LLC / / Event FDA Phase / Product Issues / Product Recall / / Facility Laboratory Test Interactions / / IndustryTerm healthcare / food / treatment of major depressive disorder / monitor for these symptoms / Hypertension Treatment / healthcare professional / prevention of seasonal affective disorder / / MedicalCondition major depressive disorder / Angle-Closure Glaucoma / seizures / seasonal affective disorder / SAD / hallucinations / arteriovenous malformation / nausea / Known hypersensitivity / Stevens-Johnson syndrome / tremor / hyponatremia / anaphylactic reactions / hypersensitivity / metabolic disorders / hypoglycemia / paranoia / head injury / abdominal pain / insomnia / congestive heart failure / panic attacks / Hypertension / obsessive compulsive disorder / bipolar depression / psychomotor restlessness / Carcinogenesis / stroke / Seizure disorder / mania / seizure / Angle Closure Glaucoma / psychiatric disorders / myocardial infarction / diabetes mellitus / cardiac disease / anorexia nervosa / dizziness / lower seizure / depression / rash / pharyngitis / tinnitus / disorders / bipolar disorder / akathisia / / MedicalTreatment antidepressant therapy / drug therapy / / Organization DOSAGE AND ADMINISTRATION / FDA / / Person Depressive Disorder / WELLBUTRIN XL / / / Position General / Major / / Product venlafaxine / efavirenz / WELLBUTRIN SR / Hypomania Antidepressant / haloperidol / linezolid / carbamazepine / bupropion hydrochloride / WELLBUTRIN XL / risperidone / Sustained-Release Tablets / WELLBUTRIN / fluoxetine / phenytoin / theophylline / Extended-release tablets / nicotine / HCl / HCl sustained-release / neuropsychiatric / / Technology Pharmacokinetics / / URL www.fda.gov/medwatch / / SocialTag